Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT05861557 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Tianjin Medical University General Hospital

Collaborators

[object Object]